Cannabis Bioscience International Holdings, Inc. announced that it has entered into a Securities Purchase Agreement with new investor 1800 DIAGONAL LENDING LLC to issue a convertible promissory note for the gross proceeds of $50,000 on March 14, 2024. The principal amount of the note is $66,000. The Note was subject to an ?original issuance discount?

of $11,000 and to an ?initial interest charge? of 13% of the principal amount of the Note, or $8,580. The Registrant paid the Lender a due diligence fee of $1,500 and the Lender?s counsel legal fees of $3,500 from the proceeds of the Note.

The net proceeds received by the Registrant after the original issuance discount, the initial interest change and payment of said fees were $50,000. The transaction is expected to close on March 18, 2024. The Note requires the Registrant to reserve a sufficient number of shares of its common stock (?Common Stock?) to provide for the issuance of Common Stock upon the full conversion of the Note, such that the Registrant is required at all times to reserve three times the number of shares that are issuable upon full conversion of the Note, to be increased or decreased based on the conversion price of the Note from time to time.

The Registrant has established an initial reserve of 435,164,835 shares.